Share Price and Basic Stock Data
Last Updated: January 3, 2026, 11:48 am
| PEG Ratio | 0.00 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Maha Rashtra Apex Corporation Ltd operates within the finance and investments sector, with a current market capitalization of ₹148 Cr. The company’s share price stands at ₹104. Revenue trends have shown a fluctuating pattern, with reported sales of ₹8.64 Cr for the year ending March 2023, a decline from ₹9.49 Cr in March 2019. Notably, quarterly sales have been sporadic, with sales recorded at ₹0 in September 2022 and June 2023, indicating potential challenges in sustaining revenue generation. In contrast, the company reported significant other income of ₹414 Cr in March 2024, contributing to a total income spike. The company’s trailing twelve months (TTM) revenue stands at ₹0.46 Cr, reflecting ongoing operational difficulties. The absence of borrowings, reported at ₹0 Cr, suggests a conservative financing strategy, although it also signals potential limitations in leveraging for growth. Overall, the revenue trajectory reflects instability, demanding strategic reassessment to secure consistent performance.
Profitability and Efficiency Metrics
The profitability metrics for Maha Rashtra Apex Corporation Ltd present a mixed picture, with a reported net profit of ₹8.77 Cr and a remarkable return on equity (ROE) of 71.2%. However, the operating profit margin (OPM) has been severely negative at -51,667%, indicating significant operational inefficiencies. The company recorded a net profit of ₹418 Cr in March 2024, a stark recovery from a net loss of ₹90 Cr in December 2023. The interest coverage ratio (ICR) is exceptionally high at 25,499.50x, reflecting the absence of interest expenses and a strong capacity to meet financial obligations. Efficiency metrics also indicate a cash conversion cycle of 0 days, demonstrating effective cash management. However, the company’s profitability is overshadowed by inconsistent operational performance, with operating profit fluctuating greatly and OPM figures illustrating severe volatility, which could deter investor confidence.
Balance Sheet Strength and Financial Ratios
Maha Rashtra Apex Corporation Ltd’s balance sheet exhibits a strong reserve position, with total reserves reported at ₹445.09 Cr, while borrowings remain at ₹0 Cr. This absence of debt positions the company favorably regarding financial stability. The book value per share, including revaluation reserves, stands at ₹329.96, suggesting substantial asset backing relative to its market price. Financial ratios indicate a low price-to-book value (P/BV) of 0.31x, positioning the stock as undervalued compared to typical sector norms. However, the current ratio of 0.27 reflects potential liquidity concerns, as it is below the ideal threshold of 1, indicating that current liabilities exceed current assets. Additionally, the return on capital employed (ROCE) is reported at 72%, indicating effective utilization of capital. These strengths in reserves and asset backing must be balanced against liquidity risks and operational inefficiencies that could impact overall financial health.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Maha Rashtra Apex Corporation Ltd shows a strong promoter holding of 62.54%, which can instill confidence among investors regarding management’s commitment to the company. The public holds 37.47% of shares, while foreign institutional investors (FIIs) are not registered, and domestic institutional investors (DIIs) hold a minimal stake of just 0.01%. The number of shareholders has increased from 10,478 in December 2022 to 15,333 in September 2025, suggesting growing interest in the company, despite its operational challenges. The high promoter holding can be viewed as a strength, indicating confidence in the company’s long-term vision. However, the lack of institutional backing may raise concerns about market perception and support. The low DII participation could indicate a cautious approach from institutional investors, reflecting uncertainty regarding the firm’s operational stability and profitability in the near term.
Outlook, Risks, and Final Insight
The outlook for Maha Rashtra Apex Corporation Ltd hinges on its ability to stabilize revenue and improve operational efficiency amidst a backdrop of significant financial strengths. The company benefits from a strong reserve position and zero debt, which could be leveraged for future growth initiatives. However, the risks include ongoing operational volatility, as evidenced by the extreme fluctuations in OPM and net profit figures. The absence of consistent revenue generation poses a substantial challenge, necessitating strategic shifts to enhance operational performance. If the company can address these operational inefficiencies and sustain revenue growth, it may attract more institutional interest and improve shareholder confidence. Conversely, failure to do so could lead to continued investor caution, affecting market perception and share price stability. Overall, the company stands at a pivotal juncture where decisive actions could define its future trajectory.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Modern Shares & Stockbrokers Ltd | 11.8 Cr. | 40.3 | 64.0/36.4 | 47.2 | 44.4 | 0.00 % | 3.32 % | 1.74 % | 10.0 |
| Monarch Networth Capital Ltd | 2,482 Cr. | 313 | 484/280 | 16.0 | 111 | 0.32 % | 33.3 % | 26.2 % | 10.0 |
| Monotype India Ltd | 30.2 Cr. | 0.43 | 1.71/0.38 | 4.19 | 0.03 | 0.00 % | 286 % | % | 1.00 |
| Multipurpose Trading & Agencies Ltd | 5.04 Cr. | 10.2 | 11.6/8.25 | 9.25 | 0.00 % | 3.68 % | 3.38 % | 10.0 | |
| Munoth Financial Services Ltd | 21.8 Cr. | 42.4 | 69.9/38.6 | 19.9 | 0.00 % | 2.41 % | 3.38 % | 10.0 | |
| Industry Average | 7,293.96 Cr | 1,366.78 | 77.89 | 3,844.57 | 0.35% | 21.71% | 14.20% | 7.28 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0 | 1 | 1 | 0 | 1 | 1 | 7 | 1 | 0 | 0 | 0 | 0 | 0 |
| Expenses | 0 | 1 | 3 | 1 | 1 | 91 | 1 | 1 | 9 | 13 | 0 | 0 | 31 |
| Operating Profit | -0 | 0 | -2 | -0 | -0 | -90 | 6 | -0 | -9 | -13 | -0 | -0 | -31 |
| OPM % | -225% | 4% | -426% | -94% | -19% | -14,314% | 82% | -92% | -1,833% | -25,920% | -50% | -840% | -51,667% |
| Other Income | 1 | 0 | 3 | 1 | 3 | 0 | 414 | 1 | 1 | 6 | 27 | 24 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | 1 | 0 | 0 | 0 | 3 | -90 | 419 | 0 | -8 | -7 | 26 | 24 | -31 |
| Tax % | 0% | 2% | -225% | 0% | 16% | 0% | 0% | 0% | -0% | 2% | 15% | 0% | 0% |
| Net Profit | 1 | 0 | 0 | 0 | 2 | -90 | 418 | 0 | -8 | -7 | 22 | 24 | -31 |
| EPS in Rs | 0.73 | 0.28 | 0.18 | 0.27 | 1.71 | -63.39 | 295.68 | 0.20 | -5.63 | -4.81 | 15.83 | 16.86 | -21.69 |
Last Updated: December 30, 2025, 2:37 am
Below is a detailed analysis of the quarterly data for Maha Rashtra Apex Corporation Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 0.00 Cr..
- For Expenses, as of Sep 2025, the value is 31.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.00 Cr. (Jun 2025) to 31.00 Cr., marking an increase of 31.00 Cr..
- For Operating Profit, as of Sep 2025, the value is -31.00 Cr.. The value appears to be declining and may need further review. It has decreased from 0.00 Cr. (Jun 2025) to -31.00 Cr., marking a decrease of 31.00 Cr..
- For OPM %, as of Sep 2025, the value is -51,667.00%. The value appears to be declining and may need further review. It has decreased from -840.00% (Jun 2025) to -51,667.00%, marking a decrease of 50,827.00%.
- For Other Income, as of Sep 2025, the value is 0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 24.00 Cr. (Jun 2025) to 0.00 Cr., marking a decrease of 24.00 Cr..
- For Interest, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 0.00 Cr..
- For Depreciation, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 0.00 Cr..
- For Profit before tax, as of Sep 2025, the value is -31.00 Cr.. The value appears to be declining and may need further review. It has decreased from 24.00 Cr. (Jun 2025) to -31.00 Cr., marking a decrease of 55.00 Cr..
- For Tax %, as of Sep 2025, the value is 0.00%. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 0.00%.
- For Net Profit, as of Sep 2025, the value is -31.00 Cr.. The value appears to be declining and may need further review. It has decreased from 24.00 Cr. (Jun 2025) to -31.00 Cr., marking a decrease of 55.00 Cr..
- For EPS in Rs, as of Sep 2025, the value is -21.69. The value appears to be declining and may need further review. It has decreased from 16.86 (Jun 2025) to -21.69, marking a decrease of 38.55.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 5:01 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1.55 | 2.03 | 1.31 | 8.75 | 10.04 | 9.49 | 5.41 | 8.38 | 7.95 | 8.64 | 9.46 | 7.50 | 0.46 |
| Expenses | 1.32 | 5.12 | 2.58 | 4.12 | 4.89 | 5.19 | 6.51 | 3.15 | 8.55 | 51.88 | 50.90 | 2.81 | 44.99 |
| Operating Profit | 0.23 | -3.09 | -1.27 | 4.63 | 5.15 | 4.30 | -1.10 | 5.23 | -0.60 | -43.24 | -41.44 | 4.69 | -44.53 |
| OPM % | 14.84% | -152.22% | -96.95% | 52.91% | 51.29% | 45.31% | -20.33% | 62.41% | -7.55% | -500.46% | -438.05% | 62.53% | -9,680.43% |
| Other Income | 1.22 | 6.09 | 3.43 | 2.92 | 0.95 | 6.81 | 15.23 | 26.97 | 2.58 | 1.52 | 2.56 | 335.21 | 57.49 |
| Interest | 2.94 | 2.78 | 2.15 | 1.59 | 1.43 | 1.08 | 0.39 | 0.03 | 0.02 | 0.00 | 0.02 | 0.00 | -0.02 |
| Depreciation | 0.24 | 0.03 | 0.06 | 0.03 | 0.03 | 0.05 | 0.03 | 0.03 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 |
| Profit before tax | -1.73 | 0.19 | -0.05 | 5.93 | 4.64 | 9.98 | 13.71 | 32.14 | 1.92 | -41.76 | -38.94 | 339.86 | 12.94 |
| Tax % | 2.31% | 57.89% | 60.00% | 1.35% | 16.59% | -0.30% | 0.07% | -4.92% | 30.21% | 0.26% | 3.90% | 1.22% | |
| Net Profit | -1.78 | 0.07 | -0.08 | 29.06 | 53.95 | 10.02 | 13.70 | 33.72 | 1.34 | -41.88 | -40.46 | 335.72 | 8.77 |
| EPS in Rs | -1.26 | 0.05 | -0.06 | 20.54 | 38.13 | 7.08 | 9.68 | 23.83 | 0.95 | -29.60 | -28.59 | 237.26 | 6.19 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 103.93% | -214.29% | 36425.00% | 85.65% | -81.43% | 36.73% | 146.13% | -96.03% | -3225.37% | 3.39% | 929.76% |
| Change in YoY Net Profit Growth (%) | 0.00% | -318.22% | 36639.29% | -36339.35% | -167.08% | 118.15% | 109.40% | -242.16% | -3129.35% | 3228.76% | 926.37% |
Maha Rashtra Apex Corporation Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -4% |
| 5 Years: | -24% |
| 3 Years: | -44% |
| TTM: | -90% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 20% |
| 5 Years: | -4% |
| 3 Years: | 167% |
| TTM: | -93% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 22% |
| 5 Years: | 11% |
| 3 Years: | 8% |
| 1 Year: | -41% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 29% |
| 3 Years: | 35% |
| Last Year: | 2% |
Last Updated: September 5, 2025, 10:10 am
Balance Sheet
Last Updated: December 4, 2025, 1:36 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 14.11 | 14.11 | 14.11 | 14.11 | 14.12 | 14.12 | 14.12 | 14.12 | 14.12 | 14.12 | 14.12 | 14.12 | 14.12 |
| Reserves | -86.66 | -86.63 | -86.75 | 22.98 | 76.83 | 87.29 | 101.01 | 134.77 | 136.27 | 98.83 | 431.82 | 451.72 | 445.09 |
| Borrowings | 3.53 | 9.52 | 0.48 | 5.94 | 5.62 | 5.93 | 5.93 | 0.32 | 0.32 | 0.39 | 0.50 | 0.32 | 0.00 |
| Other Liabilities | 144.36 | 142.98 | 132.02 | 109.01 | 104.57 | 103.19 | 107.12 | 111.39 | 109.88 | 95.68 | 87.36 | 76.96 | 76.99 |
| Total Liabilities | 75.34 | 79.98 | 59.86 | 152.04 | 201.14 | 210.53 | 228.18 | 260.60 | 260.59 | 209.02 | 533.80 | 543.12 | 536.20 |
| Fixed Assets | 6.71 | 6.92 | 6.86 | 3.03 | 3.01 | 2.90 | 2.95 | 2.92 | 2.88 | 2.85 | 2.77 | 3.63 | 3.62 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 19.03 | 18.81 | 18.90 | 139.19 | 190.46 | 196.09 | 209.31 | 238.20 | 235.59 | 187.92 | 504.34 | 512.61 | 504.74 |
| Other Assets | 49.60 | 54.25 | 34.10 | 9.82 | 7.67 | 11.54 | 15.92 | 19.48 | 22.12 | 18.25 | 26.69 | 26.88 | 27.84 |
| Total Assets | 75.34 | 79.98 | 59.86 | 152.04 | 201.14 | 210.53 | 228.18 | 260.60 | 260.59 | 209.02 | 533.80 | 543.12 | 536.20 |
Below is a detailed analysis of the balance sheet data for Maha Rashtra Apex Corporation Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 14.12 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 14.12 Cr..
- For Reserves, as of Sep 2025, the value is 445.09 Cr.. The value appears to be declining and may need further review. It has decreased from 451.72 Cr. (Mar 2025) to 445.09 Cr., marking a decrease of 6.63 Cr..
- For Borrowings, as of Sep 2025, the value is 0.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 0.32 Cr. (Mar 2025) to 0.00 Cr., marking a decrease of 0.32 Cr..
- For Other Liabilities, as of Sep 2025, the value is 76.99 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 76.96 Cr. (Mar 2025) to 76.99 Cr., marking an increase of 0.03 Cr..
- For Total Liabilities, as of Sep 2025, the value is 536.20 Cr.. The value appears to be improving (decreasing). It has decreased from 543.12 Cr. (Mar 2025) to 536.20 Cr., marking a decrease of 6.92 Cr..
- For Fixed Assets, as of Sep 2025, the value is 3.62 Cr.. The value appears to be declining and may need further review. It has decreased from 3.63 Cr. (Mar 2025) to 3.62 Cr., marking a decrease of 0.01 Cr..
- For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Investments, as of Sep 2025, the value is 504.74 Cr.. The value appears to be declining and may need further review. It has decreased from 512.61 Cr. (Mar 2025) to 504.74 Cr., marking a decrease of 7.87 Cr..
- For Other Assets, as of Sep 2025, the value is 27.84 Cr.. The value appears strong and on an upward trend. It has increased from 26.88 Cr. (Mar 2025) to 27.84 Cr., marking an increase of 0.96 Cr..
- For Total Assets, as of Sep 2025, the value is 536.20 Cr.. The value appears to be declining and may need further review. It has decreased from 543.12 Cr. (Mar 2025) to 536.20 Cr., marking a decrease of 6.92 Cr..
Notably, the Reserves (445.09 Cr.) exceed the Borrowings (0.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -3.30 | -12.61 | -1.75 | -1.31 | -0.47 | -1.63 | -7.03 | 4.91 | -0.92 | -43.63 | -41.94 | 4.37 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 2,131 | 1,453 | 1,513 | 15 | 16 | 27 | 18 | 8 | 9 | 5 | 8 | 0 |
| Inventory Days | ||||||||||||
| Days Payable | ||||||||||||
| Cash Conversion Cycle | 2,131 | 1,453 | 1,513 | 15 | 16 | 27 | 18 | 8 | 9 | 5 | 8 | 0 |
| Working Capital Days | -26,591 | -21,343 | -27,216 | -4,730 | -3,952 | -4,142 | -7,176 | -4,515 | -4,571 | -3,675 | -2,747 | -2,865 |
| ROCE % | 8% | 4% | 12% | 23% | -0% | -33% | -15% | 72% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 13.95 | 245.82 | -29.72 | 0.95 | 23.93 |
| Diluted EPS (Rs.) | 13.95 | 245.82 | -29.72 | 0.95 | 23.93 |
| Cash EPS (Rs.) | 8.51 | 5.53 | 3.67 | 3.65 | 5.83 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 329.96 | 326.43 | 80.01 | 106.53 | 105.47 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 329.96 | 326.43 | 80.01 | 106.53 | 105.47 |
| Revenue From Operations / Share (Rs.) | 0.96 | 6.17 | 1.51 | 2.76 | 2.17 |
| PBDIT / Share (Rs.) | 3.61 | 4.92 | 2.91 | 3.20 | 3.86 |
| PBIT / Share (Rs.) | 3.59 | 4.89 | 2.88 | 3.17 | 3.84 |
| PBT / Share (Rs.) | 11.43 | 6.57 | 3.73 | 4.04 | 4.69 |
| Net Profit / Share (Rs.) | 8.49 | 5.50 | 3.65 | 3.63 | 5.81 |
| NP After MI And SOA / Share (Rs.) | 237.80 | 245.37 | -29.66 | 0.95 | 23.88 |
| PBDIT Margin (%) | 374.74 | 79.63 | 192.90 | 116.10 | 177.81 |
| PBIT Margin (%) | 372.06 | 79.17 | 191.00 | 115.16 | 176.75 |
| PBT Margin (%) | 1185.26 | 106.48 | 247.00 | 146.51 | 215.83 |
| Net Profit Margin (%) | 880.65 | 89.09 | 241.67 | 131.50 | 267.43 |
| NP After MI And SOA Margin (%) | 24669.02 | 3975.34 | -1966.06 | 34.47 | 1099.83 |
| Return on Networth / Equity (%) | 72.06 | 75.16 | -37.07 | 0.89 | 22.64 |
| Return on Capital Employeed (%) | 1.08 | 1.49 | 3.59 | 2.98 | 3.63 |
| Return On Assets (%) | 61.81 | 63.13 | -20.03 | 0.51 | 12.93 |
| Asset Turnover Ratio (%) | 0.00 | 0.02 | 0.00 | 0.01 | 0.00 |
| Current Ratio (X) | 0.27 | 0.19 | 0.14 | 0.16 | 0.13 |
| Quick Ratio (X) | 0.27 | 0.19 | 0.14 | 0.16 | 0.13 |
| Interest Coverage Ratio (X) | 25499.50 | 475.29 | 1521.81 | 273.88 | 179.32 |
| Interest Coverage Ratio (Post Tax) (X) | 4589.50 | 368.69 | 1464.81 | 236.26 | 230.29 |
| Enterprise Value (Cr.) | 143.62 | 185.77 | 122.56 | 126.99 | 87.84 |
| EV / Net Operating Revenue (X) | 105.53 | 21.32 | 57.54 | 32.63 | 28.65 |
| EV / EBITDA (X) | 28.16 | 26.77 | 29.83 | 28.10 | 16.11 |
| MarketCap / Net Operating Revenue (X) | 107.89 | 21.39 | 59.02 | 33.89 | 30.32 |
| Price / BV (X) | 0.31 | 0.40 | 1.11 | 0.87 | 0.62 |
| Price / Net Operating Revenue (X) | 108.00 | 21.39 | 59.05 | 33.90 | 30.33 |
| EarningsYield | 2.29 | 1.86 | -0.33 | 0.01 | 0.36 |
After reviewing the key financial ratios for Maha Rashtra Apex Corporation Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 13.95. This value is within the healthy range. It has decreased from 245.82 (Mar 24) to 13.95, marking a decrease of 231.87.
- For Diluted EPS (Rs.), as of Mar 25, the value is 13.95. This value is within the healthy range. It has decreased from 245.82 (Mar 24) to 13.95, marking a decrease of 231.87.
- For Cash EPS (Rs.), as of Mar 25, the value is 8.51. This value is within the healthy range. It has increased from 5.53 (Mar 24) to 8.51, marking an increase of 2.98.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 329.96. It has increased from 326.43 (Mar 24) to 329.96, marking an increase of 3.53.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 329.96. It has increased from 326.43 (Mar 24) to 329.96, marking an increase of 3.53.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 0.96. It has decreased from 6.17 (Mar 24) to 0.96, marking a decrease of 5.21.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 3.61. This value is within the healthy range. It has decreased from 4.92 (Mar 24) to 3.61, marking a decrease of 1.31.
- For PBIT / Share (Rs.), as of Mar 25, the value is 3.59. This value is within the healthy range. It has decreased from 4.89 (Mar 24) to 3.59, marking a decrease of 1.30.
- For PBT / Share (Rs.), as of Mar 25, the value is 11.43. This value is within the healthy range. It has increased from 6.57 (Mar 24) to 11.43, marking an increase of 4.86.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 8.49. This value is within the healthy range. It has increased from 5.50 (Mar 24) to 8.49, marking an increase of 2.99.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 237.80. This value is within the healthy range. It has decreased from 245.37 (Mar 24) to 237.80, marking a decrease of 7.57.
- For PBDIT Margin (%), as of Mar 25, the value is 374.74. This value is within the healthy range. It has increased from 79.63 (Mar 24) to 374.74, marking an increase of 295.11.
- For PBIT Margin (%), as of Mar 25, the value is 372.06. This value exceeds the healthy maximum of 20. It has increased from 79.17 (Mar 24) to 372.06, marking an increase of 292.89.
- For PBT Margin (%), as of Mar 25, the value is 1,185.26. This value is within the healthy range. It has increased from 106.48 (Mar 24) to 1,185.26, marking an increase of 1,078.78.
- For Net Profit Margin (%), as of Mar 25, the value is 880.65. This value exceeds the healthy maximum of 10. It has increased from 89.09 (Mar 24) to 880.65, marking an increase of 791.56.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 24,669.02. This value exceeds the healthy maximum of 20. It has increased from 3,975.34 (Mar 24) to 24,669.02, marking an increase of 20,693.68.
- For Return on Networth / Equity (%), as of Mar 25, the value is 72.06. This value is within the healthy range. It has decreased from 75.16 (Mar 24) to 72.06, marking a decrease of 3.10.
- For Return on Capital Employeed (%), as of Mar 25, the value is 1.08. This value is below the healthy minimum of 10. It has decreased from 1.49 (Mar 24) to 1.08, marking a decrease of 0.41.
- For Return On Assets (%), as of Mar 25, the value is 61.81. This value is within the healthy range. It has decreased from 63.13 (Mar 24) to 61.81, marking a decrease of 1.32.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.00. It has decreased from 0.02 (Mar 24) to 0.00, marking a decrease of 0.02.
- For Current Ratio (X), as of Mar 25, the value is 0.27. This value is below the healthy minimum of 1.5. It has increased from 0.19 (Mar 24) to 0.27, marking an increase of 0.08.
- For Quick Ratio (X), as of Mar 25, the value is 0.27. This value is below the healthy minimum of 1. It has increased from 0.19 (Mar 24) to 0.27, marking an increase of 0.08.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 25,499.50. This value is within the healthy range. It has increased from 475.29 (Mar 24) to 25,499.50, marking an increase of 25,024.21.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 4,589.50. This value is within the healthy range. It has increased from 368.69 (Mar 24) to 4,589.50, marking an increase of 4,220.81.
- For Enterprise Value (Cr.), as of Mar 25, the value is 143.62. It has decreased from 185.77 (Mar 24) to 143.62, marking a decrease of 42.15.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 105.53. This value exceeds the healthy maximum of 3. It has increased from 21.32 (Mar 24) to 105.53, marking an increase of 84.21.
- For EV / EBITDA (X), as of Mar 25, the value is 28.16. This value exceeds the healthy maximum of 15. It has increased from 26.77 (Mar 24) to 28.16, marking an increase of 1.39.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 107.89. This value exceeds the healthy maximum of 3. It has increased from 21.39 (Mar 24) to 107.89, marking an increase of 86.50.
- For Price / BV (X), as of Mar 25, the value is 0.31. This value is below the healthy minimum of 1. It has decreased from 0.40 (Mar 24) to 0.31, marking a decrease of 0.09.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 108.00. This value exceeds the healthy maximum of 3. It has increased from 21.39 (Mar 24) to 108.00, marking an increase of 86.61.
- For EarningsYield, as of Mar 25, the value is 2.29. This value is below the healthy minimum of 5. It has increased from 1.86 (Mar 24) to 2.29, marking an increase of 0.43.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Maha Rashtra Apex Corporation Ltd:
- Net Profit Margin: 880.65%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 1.08% (Industry Average ROCE: 21.71%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 72.06% (Industry Average ROE: 14.2%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 4589.5
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.27
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 0 (Industry average Stock P/E: 77.89)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 880.65%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Finance & Investments | 3rd Floor, Front Wing, North Block, Bengaluru Karnataka 560042 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. K B Shetty | Chairman |
| Mr. Aspi Nariman Katgara | Managing Director |
| Mrs. V B Jyothi | Director |
| Mr. Nagarajan Sivarmakrishnan | Director |
| Mr. Yazdin Jimmy Mistry | Director |
| Mrs. Vidya Mananjay More | Director |
FAQ
What is the intrinsic value of Maha Rashtra Apex Corporation Ltd?
Maha Rashtra Apex Corporation Ltd's intrinsic value (as of 04 January 2026) is ₹2832.34 which is 2623.40% higher the current market price of ₹104.00, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's ₹148 Cr. market cap, FY2025-2026 high/low of ₹158/69.0, reserves of ₹445.09 Cr, and liabilities of ₹536.20 Cr.
What is the Market Cap of Maha Rashtra Apex Corporation Ltd?
The Market Cap of Maha Rashtra Apex Corporation Ltd is 148 Cr..
What is the current Stock Price of Maha Rashtra Apex Corporation Ltd as on 04 January 2026?
The current stock price of Maha Rashtra Apex Corporation Ltd as on 04 January 2026 is ₹104.
What is the High / Low of Maha Rashtra Apex Corporation Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Maha Rashtra Apex Corporation Ltd stocks is ₹158/69.0.
What is the Stock P/E of Maha Rashtra Apex Corporation Ltd?
The Stock P/E of Maha Rashtra Apex Corporation Ltd is .
What is the Book Value of Maha Rashtra Apex Corporation Ltd?
The Book Value of Maha Rashtra Apex Corporation Ltd is 325.
What is the Dividend Yield of Maha Rashtra Apex Corporation Ltd?
The Dividend Yield of Maha Rashtra Apex Corporation Ltd is 0.00 %.
What is the ROCE of Maha Rashtra Apex Corporation Ltd?
The ROCE of Maha Rashtra Apex Corporation Ltd is 72.0 %.
What is the ROE of Maha Rashtra Apex Corporation Ltd?
The ROE of Maha Rashtra Apex Corporation Ltd is 71.2 %.
What is the Face Value of Maha Rashtra Apex Corporation Ltd?
The Face Value of Maha Rashtra Apex Corporation Ltd is 10.0.